Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar 1;6(3):19.
doi: 10.3390/foods6030019.

Red Yeast Rice

Thu Nguyen  1 , Mitchell Karl  2 , Antonello Santini  3
Affiliations

Red Yeast Rice

Thu Nguyen et al. Foods. .

Abstract

Red yeast rice (RYR), produced by the fermentation of the Monascus purpureus mold, has been used for a long time in Asian cuisine and traditional medicine. It consists of multiple bioactive substances, including monacolins, which potentially can be used as a nutraceutical. Monacolin K, which is chemically identical to lovastatin, has been recognized as responsible for the cholesterolreducing effect of this compound. While the European Food Safety Authority maintains that the use of monacolin K from RYR preparations of at least 10 mg can produce a normal blood cholesterol level, the United States Food and Drug Administration considers monacolin K, due to its similarity with lovastatin, an unapproved drug, and therefore marketing of products that label the monacolin content is prohibited. This mini-review summarizes the benefit of RYR in hyperlipidemia, maintains RYR use as a food, and addresses the importance of regulation regarding RYR and the need for clinical data and clear label information for consumers with reference to a toxin-free, nonaugmented, standardized amount of monacolins.

Keywords: health; lovastatin; nutraceutical; red yeast rice; safety.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. DeFelice S.L. The nutraceutical revolution: its impact on food industry R&D. Trends Food Sci. Tech. 1995;6:59–61.
    1. Otles S., Ozlem C. Safety considerations of nutraceuticals and functional foods. Novel Technol. Food Sci. 2012;7:121–136.
    1. Yates A.A., Erdman J.W., Jr., Shao A., Dolan L.C., Griffiths J.C. Bioactive nutrients-time for tolerable upper intake levels to address safety. Rep. Prog. Phys. 2017;84:94–101. doi: 10.1016/j.yrtph.2017.01.002. - DOI - PubMed
    1. Burke F.M. Red yeast rice for the treatment of dyslipidemia. Curr. Atheroscler. Rep. 2015 doi: 10.1007/s11883-015-0495-8. - DOI - PubMed
    1. Patel S. Functional food red yeast rice (RYR) for metabolic syndrome amelioration: a review on pros and cons. World J. Microb. Biot. 2016;32:2035–2042. doi: 10.1007/s11274-016-2035-2. - DOI - PubMed

LinkOut - more resources